Fair Isaac Corporation develops analytic, software, and data management products and services that enable businesses to automate, enhance, and connect decisions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Scores and Software. The Software segment offers pre-configured decision management solution designed for various business problems or processes, such as marketing, account origination, customer management, customer engagement, fraud detection, financial crimes compliance, collection, and marketing, as well as associated professional services. This segment also provides FICO Platform, a modular software offering designed to support advanced analytic and decision use cases, as well as stand-alone analytic and decisioning software that can be configured by customers to address a wide range of business use cases. The Scores segment provides business-to-business scoring solutions and services for consumers that give clients access to analytics to be integrated into their transaction streams and decision-making processes, as well as business-to-consumer scoring solutions comprising myFICO.com subscription offerings. Fair Isaac Corporation markets its products and services primarily through its direct sales organization and indirect channels, as well as online. The company was formerly known as Fair Isaac & Company, Inc. and changed its name to Fair Isaac Corporation in July 1992. Fair Isaac Corporation was founded in 1956 and is headquartered in Bozeman, Montana.

Fair Isaac Corporation

Verana Health uses data analytics and technology to provide insights aimed at improving patient care in medicine.

Verana Health

Plexus offers technological services and solutions developed on demand for various industries, including mobility solutions and a cryptocurrency payment service platform self-described as innovative.

Plexus

FICO provides analytics and decision management technology to help organizations better understand and engage with their customers.

Metric
Company Name	Fair Isaac Corporation	Verana Health	Plexus
Symbol	FICO
MSH ID	COM:FICO	COM:VERANAHEALTH	ES:PLEXUS
Market	STOCKS	PRIVATE	PRIVATE
Sector	Technology	Healthcare & Health Services	Technology
Industry	Software - Application	Health Technology	Information Technology
Country	US	US	ES
Stage			Post-IPO
Employee Count	3.55K	51
Website	fico.com	veranahealth.com	plexus.es/en
LinkedIn		verana-health	plexus
Founders

Metric
Market Cap	37.91B
Enterprise Value
Monthly Web Traffic	116.83K	4.75K	30.90K
Web Traffic Growth	-0.09	1.49	-0.40
Valuation
Raised Capital

Metric
Revenue	1.72B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.37B
EBITDA	733.63M
Operating Income	733.63M
Net Income	512.81M
EPS	20.78
Diluted EPS	20.45
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.80
Operating Profit Margin	0.43
EBITDA Margin	0.43
Net Profit Margin	0.30
Return on Equity	-0.63
Return on Assets	0.28
Return on Capital Employed	0.56

COM:FICO

FICO

Last Close

2,337.83

22/11 21:00

Market Cap

37.91B

Beta: -

Volume Today

90.17K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	68.66
P/B Ratio	-42.84
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	30.92
EV Multiple	68.37

Metric
Days Sales Outstanding	86.49
Days Payables Outstanding	21.33
Days Inventory Outstanding	0.00
Operating Cycle	106.71
Cash Conversion Cycle	85.58
Asset Turnover	0.97

Metric
Operating Cash Flow	632.96M
Free Cash Flow	624.08M
Cash Flow to Debt	0.27
Operating Cash Flow/Sales	0.35
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	150.67M
Accounts Receivable	-34.14M
Inventory
Goodwill	782.75M
Debt to Capitalization	1.64
Debt to Assets	1.24
Current Ratio	1.31
Quick Ratio	2.04

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.08
R&D to Revenue	0.11
SG&A to Revenue